Fluence Corporation Limited · ASX:FLC
Fluence — Investor Presentation (July 2025)
11 slides from Fluence's investor presentation, Jul 31, 2025
Slide 1: Q2 & H1 2025 Results
Q2 & H1 2025 Results Sustainable Water Solutions Investor Presentation July 31, 2025
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by Fluence Corporation Limited (ASX: apply for any securities, including in any jurisdiction where, or to any person FLC). All currencies quoted as “$” are US dollars unless otherwise specified. to whom, such an offer or invitation would be unlawful. Th
Slide 3: Executive Summary
Executive Summary New and Highly • Over 100 years of experience in the water and wastewater treatment industry Experienced • Chairman, CEO, CFO, and CCO all joined within the last 3 years Leadership • Notable turnaround experience and a number of highly successful exits leading to material returns f
Slide 4: Fluence Business Segments
Fluence Business Segments The water and wastewater treatment market is highly fragmented, offering a direct opportunity for Fluence to focus on high-growth end markets MUNICIPAL WATER & WASTEWATER INDUSTRIAL WASTEWATER & BIOGAS INDUSTRIAL WATER & REUSE SEA ASIA & CHINA • Market-leading MABR technolo
Slide 5: Shifting Focus to SPS and RR
Shifting Focus to SPS and RR Focusing our business on SPS significantly improves profitability, recurring revenue and growth • Stronger focus on SPS: Ramping sales of TRANSITION TO HIGHER MARGIN SEGMENTS our unique, decentralized water and wastewater treatment solutions Illustrative increase in GM%
Slide 6: Fluence’s Strategic Transition - Revenue Segmentation
Fluence’s Strategic Transition - Revenue Segmentation Focused on growing presence in North America and transitioning from CES revenue to SPS and Recurring Revenue segments Medium-Term 2022 2023 2024 H1 2025 TARGETS GEOGRAPHY 6% 8% 9% 13% 13% 12% 12% 27% 4% 30% 7% 36% 10% • Focus on growing 11% 19% 1
Slide 7: Q2 2025 Financial Highlights
Q2 2025 Financial Highlights All numbers subject to audit Financial Summary (FY2022-25F) (1)(2) • H1 2025 Revenue of $33.1M, representing 64.7% growth over H1 2024 (US$ millions) ― Ivory Coast Addendum revenue of $12.7M was $12.0M higher than H1 $116M 2024 ― SPS revenue growth of 19.3% 30.1% 28.1% $
Slide 8: Key Recent Orders
Key Recent Orders The Company secured several notable new orders in Q2 and July 2025, including: • Eneva (Brazil): 3 separate orders totaling $3.6M ― Potable water treatment plant ― Chemical dosing system ― Sanitary wastewater treatment plant (“WWTP”) • Igor (Italy): $2.4M Anaerobic digestion of whe
Slide 9: Sales Pipeline Remains Strong; Sufficient Backlog to Drive Revenue Guidance in FY2025
Sales Pipeline Remains Strong; Sufficient Backlog to Drive Revenue Guidance in FY2025 Sales Pipeline Growth (1) • Pipeline has increased by $279M (+35%) since Q4 2023 and $55M (US$ millions) (+5%) since Q2 2024 • The total sales pipeline represents over 345 opportunities with an average project size
Slide 10: Ivory Coast Project
Ivory Coast Project Project Overview The Installation Main Works: • Value: €164M • Scope: – The design and construction of a 150,000 m³/day water treatment plant to supply drinking water to the city of Abidjan Addendum Works: • Value: €48M • Scope: – Distribution of treated water from two 5,000m³ wa
Slide 11: For further information, please contact
www.fluencecorp.com For further information, please contact: Australia United States of America Andrew Angus Thomas Pokorsky Investor Relations CEO and Managing Director E: andrewangus@overlandadvisers.com.au E: tpokorsky@fluencecorp.com P: +61 402 823 757 11